Table 3.
Baseline characteristics according to ABO Blood Groups
| Variables | A (n = 243) | B (n = 245) | O (n = 126) | AB (n = 47) | P (A vs non-A) |
|---|---|---|---|---|---|
| Age, years | 70.7 ± 10.03 | 67.76 ± 9.56 | 69.68 ± 8.68 | 69.77 ± 9.08 | 0.952 |
| Male, n (%) | 166 (68.3) | 178 (72.65) | 78 (61.9) | 31 (65.96) | 0.696 |
| HT, n (%) | 168 (69.14) | 173 (70.61) | 83 (65.87) | 35 (74.47) | 0.88 |
| DM, n (%) | 66 (27.16) | 71 (28.98) | 16 (12.7) | 7 (14.89) | 0.645 |
| CHF, n (%) | 10 (4.12) | 10 (4.08) | 6 (4.76) | 3 (6.38) | 0.355 |
| History of MI, n (%) | 26 (10.7) | 30 (12.24) | 12 (9.52) | 4 (8.51) | 0.581 |
| History of CAD, n (%) | 45 (18.52) | 53 (21.63) | 21 (16.67) | 8 (17.02) | 0.814 |
| History of PCI, n (%) | 35 (14.4) | 37 (15.1) | 12 (9.52) | 5 (10.64) | 0.88 |
| History of CABG, n (%) | 6 (2.47) | 6 (2.45) | 2 (1.59) | 1 (2.13) | 0.661 |
| Current smoker, n (%) | 144 (59.26) | 152 (62.04) | 58 (46.03) | 30 (63.83) | 0.574 |
| BMI, kg/m2 | 25.55 ± 3.76 | 24.25 ± 3.27 | 24.52 ± 2.58 | 25.39 ± 3.96 | 0.159 |
| Symptom onset time (h) | 38.92 ± 45.82 | 28.52 ± 43.67 | 33.61 ± 47.55 | 38.54 ± 47.27 | 0.762 |
| STEMI, n (%) | 165 (67.9) | 174 (71.02) | 69 (54.76) | 29 (61.7) | 0.382 |
| Anterior MI, n (%) | 122 (50.21) | 131 (53.47) | 59 (46.83) | 23 (48.94) | |
| Heart rate, bpm | 82.93 ± 18.56 | 80.91 ± 15.39 | 80.43 ± 19.96 | 73.23 ± 12.54 | 0.401 |
| SBP, mmHg | 127.33 ± 25.55 | 123.88 ± 23.06 | 125.57 ± 23.51 | 128.46 ± 20.68 | 0.609 |
| DBP, mmHg | 71.06 ± 12.95 | 73.38 ± 11.75 | 75.32 ± 11.26 | 69.85 ± 9.65 | 0.505 |
| KILLIP class | |||||
| KILLIP I, n (%) | 128 (52.67) | 129 (52.65) | 63 (50) | 27 (57.45) | 0.371 |
| KILLIP II, n (%) | 85 (34.98) | 88 (35.92) | 46 (36.51) | 13 (26.66) | 0.296 |
| KILLIP III, n (%) | 17 (7) | 18 (7.35) | 9 (7.14) | 3 (6.38) | 0.682 |
| KILLIP IV, n (%) | 13 (5.35) | 10 (4.08) | 8 (6.35) | 4 (8.51) | 0.267 |
| β-RB in 24 h, n (%) | 120 (49.38) | 117 (47.76) | 61 (48.41) | 25 (53.19) | 0.611 |
| ACEI/ARB in 24 h, n (%) | 29 (11.93) | 26 (10.61) | 15 (11.9) | 6 (12.77) | 0.68 |
| ESR, mm/h | 15.72 ± 14.52 | 18.17 ± 13.7 | 16.93 ± 13.81 | 13.69 ± 10 | 0.574 |
| HBA1C, % | 6.74 ± 1.25 | 6.49 ± 1.07 | 6.33 ± 1.3 | 6.19 ± 0.48 | 0.058 |
| BNP (pg/ml) | 760.25 (441.3, 1018.5) | 641.9 (316.85, 1120) | 694.22 (306.28, 994.18) | 667.02 (285.95, 1010,6) | 0.236 |
| WBC, *109/L | 10.5 ± 4.17 | 10.36 ± 3.84 | 9.63 ± 3.93 | 9.36 ± 2.01 | 0.298 |
| RBC, *1012/L | 4.21 ± 0.9 | 4.14 ± 0.58 | 4.2 ± 0.48 | 4.02 ± 0.48 | 0.097 |
| Hb, g/L | 128.28 ± 22.41 | 127.59 ± 19.56 | 129.14 ± 15.23 | 124.33 ± 13.54 | 0.328 |
| D-dimer, mg/L FEU | 1.31 ± 1.21 | 1.37 ± 1.63 | 1.32 ± 0.65 | 1.11 ± 0.44 | 0.67 |
| CK-MB, ng/ml | 22 (5.95, 92.65) | 28.9 (6.4, 127.03) | 17.4 (1.9, 55.85) | 12.1 (1.7, 43.85) | 0.877 |
| CTnI, ng/ml | 7.53 (2.95, 33.7) | 11.23 (6.01, 47.83) | 5.62 (1.32, 39.65) | 7.61 (1.32, 33.65) | 0.308 |
| LDL, mmol/L | 2.58 ± 0.97 | 2.59 ± 0.79 | 2.33 ± 0.77 | 2.67 ± 0.95 | 0.15 |
| SCR, umol/L | 101.44 ± 59.81 | 103.9 ± 61.36 | 84.82 ± 21.95 | 76.5 ± 23.22 | 0.392 |
| eGFR, ml/min/1.73 m2 | 71.7 ± 30.63 | 78.32 ± 36.61 | 79.41 ± 25.42 | 89.36 ± 34.77 | 0.521 |
| SUA, umol/L | 344.81 ± 101.99 | 338.04 ± 103.9 | 311.62 ± 87.29 | 317.36 ± 51.76 | 0.56 |
| LVEDd, mm | 48.31 ± 8 | 49.26 ± 6.33 | 46.91 ± 4.86 | 47.23 ± 5.22 | 0.23 |
| LVESd, mm | 35.93 ± 8.47 | 36.04 ± 8.09 | 33.61 ± 7.27 | 36.08 ± 8.22 | 0.48 |
| LVEF (%) | 52.09 ± 10.91 | 55.16 ± 11.6 | 58.43 ± 10.62 | 55.46 ± 11.36 | 0.923 |
| GRACE RS | 182.7 ± 42.85 | 174.03 ± 44.38 | 167.36 ± 36.23 | 169.08 ± 32.71 | 0.778 |
| Primary PCI treatment, n (%) | 161 (66.26) | 166 (67.76) | 80 (63.49) | 30 (63.83) | 0.668 |
| Heart rupture, n (%) | 30 (12.35) | 18 (7.35) | 10 (7.94) | 3 (6.38) | < 0.001 |
| Mortality, n (%) | 33 (13.58) | 25 (10.2) | 12 (9.52) | 5 (10.64) | 0.024 |
Data are number (%), mean (SD), or median (IQR)
HT, hypertension; DM, diabetes mellitus; CHF, chronic heart failure; TIA, transient ischemic attack; MI, myocardial infarction; CAD, Coronary artery disease; PCI, percutaneous coronary intervention; CABG, coronary artery bypass grafting; AF, atrial fibrillation; BMI, body mass Index; STEMI, ST-segment elevation myocardial infarction; SBP, systolic blood pressure; β-RB, β-receptor blocker; ACEI, angiotensin-converting enzyme inhibitor; ARB, agiotensin Receptor Blocker; ESR, erythrocyte sedimentation rate; HBA1C. glycosylated hemoglobin; BNP, brain natriuretic peptide; WBC, white blood cell; RBC, red blood cell; Hb, haemoglobin; CK-MB, creatine kinase MB; CTnI, cardiac troponin I; LDL-C, low-density lipoprotein cholesterol; LP(a), Lipoprotein (a); SCR, serum creatinine; eGFR, estimated glomerular filtration rate; SUA, serum uric acid; LVEDd, left ventricular end-diastolic dimension; LVESd, left ventricular end- systolic dimension; LVEF, Left ventricular ejection fraction; GRACE RS, The Global Registry of Acute Coronary Events risk score; PCI, percutaneous coronary intervention